Janux Therapeutics, Inc. · NASDAQ:JANX
Janus Henderson Group PLC reported a 10.00% stake in Janux Therapeutics, Inc. (Schedule 13G/A)
Event Oct 31, 2025 · Filed Nov 7, 2025
Janus Henderson Group PLC reported a 10.00% stake in Janux Therapeutics, Inc., 6,033,949 shares, as a passive investor on Oct 31, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 10.00%
- Shares
- 6,033,949
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 10.00% | 6,033,949 |
Source
Related
- Janux Therapeutics, Inc.
- Janus Henderson Group PLC
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 12, 2026